CD8A and neoplasm: As data is accumulating and is being currently validated in clinical trials that a T cell-infiltrated and -inflamed tumor microenvironment may be a relevant predictive biomarker for clinical benefit, induction of CD3+CD8+ T cell infiltration in tumors by VV-FCU1 is of utmost importance.22,23